1. 5-year progression-free status was greatest in group 3 (triple therapy) and lowest in group 1 (pelvic bed radiotherapy alone)....
1. Complete clinical response at 6 months was similar in both the topical imiquimod and surgery group. 2. Invasive disease...
1. EV71vac showed a vaccine efficacy of 96.8% against EV71-associated diseases. 2. Majority of adverse events were mild and self-limited...
1. Patients who underwent segmentectomy reported a significantly greater 5-year overall survival than those who underwent lobectomy (94.3% vs. 91.1%)....
1. Asundexian 50 mg resulted in a lower rate of bleeding compared to apixaban 5 mg twice daily. 2. The...
1. Seroconversion at 84 days was greater in the ZyCoV-D group compared to placebo. 2. The occurrence of adverse events...
1. Chlorfenapyr LLINs provided significantly better protection than pyriproxyfen and piperonyl-butoxide subtypes. 2. Chlorfenapyr LLINs costed an additional $19 US...
1. Gefapixant 45 mg twice a day showed significant reductions in chronic cough over 12-24 weeks compared to placebo. 2....
1. There was no significant difference in the primary composite endpoint between the interatrial shunt and sham procedure groups. 2....
1. Ischemic stroke patients assigned to aspirin-only, heparin-only, or both, had worse Modified Rankin Scale scores compared to those with...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.